Stepan (NYSE:SCL) Stock Rating Lowered by Scotiabank

Stepan (NYSE:SCL) was downgraded by stock analysts at Scotiabank to a “sector underperform” rating in a research report issued to clients and investors on Tuesday, Stock Target Advisor reports. They presently have a $20.00 price target on the basic materials company’s stock. Scotiabank’s target price points to a potential downside of 79.08% from the stock’s current price.

SCL has been the topic of several other reports. Zacks Investment Research raised shares of Stepan from a “sell” rating to a “hold” rating in a report on Wednesday, July 24th. BMO Capital Markets decreased their price target on shares of Stepan from $28.00 to $20.00 and set an “outperform” rating on the stock in a report on Friday, August 9th. Royal Bank of Canada started coverage on shares of Stepan in a report on Wednesday, July 3rd. They set a “sector perform” rating and a $21.00 price target on the stock. Finally, ValuEngine lowered shares of Stepan from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $54.14.

SCL stock opened at $95.62 on Tuesday. The company has a current ratio of 2.69, a quick ratio of 1.97 and a debt-to-equity ratio of 0.28. Stepan has a 12 month low of $69.17 and a 12 month high of $101.84. The company has a market cap of $2.15 billion, a price-to-earnings ratio of 19.59 and a beta of 1.27. The firm has a 50-day moving average price of $93.68.

Stepan (NYSE:SCL) last released its earnings results on Wednesday, July 24th. The basic materials company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.31 by $0.19. Stepan had a net margin of 5.39% and a return on equity of 14.19%. The firm had revenue of $473.00 million for the quarter, compared to analyst estimates of $519.20 million. During the same period last year, the firm earned $1.38 EPS. The business’s quarterly revenue was down 9.0% compared to the same quarter last year. As a group, equities research analysts forecast that Stepan will post 5.05 EPS for the current fiscal year.

In related news, VP Frank Pacholec sold 1,931 shares of Stepan stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $91.94, for a total transaction of $177,536.14. Following the sale, the vice president now directly owns 8,664 shares in the company, valued at approximately $796,568.16. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Edward J. Wehmer sold 1,200 shares of Stepan stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $90.52, for a total transaction of $108,624.00. Following the sale, the director now owns 10,253 shares in the company, valued at $928,101.56. The disclosure for this sale can be found here. Insiders have sold a total of 16,735 shares of company stock worth $1,623,252 over the last ninety days. 11.40% of the stock is currently owned by insiders.

Large investors have recently bought and sold shares of the stock. FMR LLC boosted its position in Stepan by 189.0% during the 1st quarter. FMR LLC now owns 341 shares of the basic materials company’s stock worth $30,000 after buying an additional 223 shares during the period. Krane Funds Advisors LLC acquired a new stake in Stepan during the 2nd quarter worth approximately $58,000. DekaBank Deutsche Girozentrale acquired a new stake in Stepan during the 2nd quarter worth approximately $66,000. Quantamental Technologies LLC acquired a new stake in Stepan during the 2nd quarter worth approximately $74,000. Finally, Contravisory Investment Management Inc. acquired a new stake in Stepan during the 2nd quarter worth approximately $151,000. Institutional investors and hedge funds own 72.22% of the company’s stock.

Stepan Company Profile

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products.

See Also: Capital Gains Distribution

Stock Target Advisor

Analyst Recommendations for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply